In the BioHarmony Drug Report Database
Lesinurad
Zurampic (lesinurad) is a small molecule pharmaceutical. Lesinurad was first approved as Zurampic on 2015-12-22. It is used to treat hyperuricemia in the USA. It is known to target solute carrier family 22 member 12. Zurampic’s patents are valid until 2032-02-29 (FDA).
Trade Name
|
Zurampic |
|---|---|
Common Name
|
lesinurad |
ChEMBL ID
|
CHEMBL2105720 |
Indication
|
hyperuricemia |
Drug Class
|
Urate transporter inhibitors |
Image (chem structure or protein)